Category Archives: CEO

InnovaCare Health CEO Dr. Rick Shinto and COO Penelope Kokkinides Lead in the Industry of Healthcare Management

InnovaCare Health oversees a vast network of healthcare providers in North America and is committed to the administration of the highest caliber of medical assistance. The company is currently led by Chief Executive Officer, Dr. Richard A. Shinto, an M.D. with twenty years of experience in both clinical settings and in medical operations management. Dr. Shinto received his B.S. from Irvine’s University of California, his medical degree from Stony Brook’s State University of New York, and his M.B.A. from the University of Redlands.

Dr. Rick Shinto’s career began with him working as an intern, and later he practiced, in southern California, as an pulmonologist. He then served as MedPartners’s Corporate Vice President of Medical Management before leaving to work for Orange County’s Cal Optima Health Plan and to act as their Chief Medical Officer. Dr. Rick Shinto was later employed by Medical Pathways Management Company in the capacities of Chief Operating Officer and Chief Medical Officer. He later joined NAMM California as their Chief Medical Officer.

In 2008, Dr. Shinto became a member of North American Medical Management of Illinois, Inc.’s management team and was Aveta Inc.’s President and Chief Executive Officer until the company was sold in 2012. He then became MMM Healthcare, Inc. and PMC Medicare Choice, Inc.’s Chief Executive Officer and later the Chief Executive Officer for Aveta Inc. Dr. Shinto currently is MMM Healthcare, Inc.’s Chief Executive Officer and is InnovaCare Health Solutions, LLC’s Chief Executive Officer and President.

Acting as Chief Administrative Officer for InnovaCare Health Solutions, LLC, is Penelope Kokkinides, who holds a master’s degree in pubic health from Columbia University. She has served as Chief Executive Officer for Aveta Inc. and for Touchstone Health HMO, Inc. She has more than 15 years experience and specializes in managed healthcare and in government programs.

InnovaCare Health is a provider of Medicare Advantage programs and services for physicians with practices. They host two plans, MMM Healthcare, Inc. and PMC Medicare Choice, Inc., both of which have earned the National Committee for Quality Assurance’s Commendable Accreditation accolade. PMC Medicare Choice, Inc. has a client base of more than 230,000 members and MMM Healthcare, Inc. is one of the plans with the fastest rate of growth in the United States.

InnovaCare Health’s services for physicians’ practices serve to use the latest in quality technology to streamline the processes of providing healthcare. Their affiliate, MSO of Puerto Rico, LLC (MSO), helps provide their clients with solutions to more effectively and efficiently administer the best in health care services. InnovaCare Health’s mission is to create top-notch partnerships in the healthcare industry and to make sure that patients are always put first.

Read more:
InnovaCare Health Announces Three Additions To Leadership Team
InnovaCare Health hires new healthcare execs into leadership team

Stephen Murray – the Private Equity Specialist who Drove CCMP Capital to Success

Stephen Murray left his positions as the CEO and President of a private equity company (CCMP Capital) located in New York in February 2015, five months after the firm had yielded $3.6 billion in financing. Murray and Greg Brenneman were the two CCMP officials who appeared on SEC records for that fund. He was also one of the five control individuals that CCMP listed on its Form ADV. The management team of CCMP said that Murray’s exit was due to “health-related” reasons.

Murray’s achievements at CCMP

Stephen Murray CCMP Capital is debatably one of the individuals who played a significant role in turning CCMP into a successful private equity firm. He had unsurpassed professional experience and expertise in private equity and distressed investment. Murray masterminded the separation of CCMP Capital from the renowned JP Morgan Chase. The executive board appointed him as the president and CEO of the firm, a few months after the spinout. Mr. Murray was one of the most experienced senior employees that CCMP was privileged to have. He had witnessed the company grow from infancy to leading private equity firm on the global marketplace. Therefore, he helped the company to remain relevant in the market even during times of economic recessions.

Read more: Former CCMP CEO Stephen Murray Dies at 52

Murray’s fantastic career outline

Murray was a student at Boston College who graduated in 1984 with an undergrad in economics. Murray obtained an internship position at the Manufacturers Hanover Corporation. In 1989, he added an advanced degree in Business Administration into his academic arsenal. In the same year, he became an employee of MH Equity Corporation that amalgamated its finance unit with the Hanover’s private equity section. Several mergers and name changes followed until the birth of CCMP Capital. Stephen Murray brought new ideas to his company by serving on the boards of other leading firms, including the Generac Power Systems, Warner Chilcott, Cabela’s, AMC Entertainment, and Legacy Hospital Partners. These companies also benefited from his in-depth knowledge and expertise in private equity firm.

Philanthropic acts

Stephen Murray established a culture of corporate charity at CCMP. He managed to expand his philanthropic endeavors on a worldwide scale. Both local and global foundations received massive support from Murray. Make-A-Wish Foundation, which sponsors students to attend University, graduate, and builds a successful career received generous donations from him. Murray financially supported the Lower County Fairfield County Food Bank, Stamford Museum, and Boston College. He served on the Trustees Board of Boston College as a Vice Chairman.


Susan McGalla Is Fighting For Women

In today’s world, it is more true than ever: women need to stick together on While it can be a dog-eat-dog world out there, it does not mean that women have to be at each other’s throats. That does not help anyone out and it just causes unnecessary problems. The key is to stand together, be there for one another, and help each other. Not everything in life has to be a competition. If there is anyone that knows this, it is Susan McGalla. She knows all about being there for her fellow women. Susan McGalla recently gave out some advice for women on how to land the job and stay successful in business.

Now, one must recall this is a woman that is the founder of P3 Executive Consulting, LLC, and Susan McGalla is an expert consultant. She had paid her dues and throughout paying her dues, she has learned a lot along the way and now she wants to take what McGalla has learned and pass it onto to fellow women that are trying to land a business job and stay there for a long period of time. When someone goes in for a job interview, they have to sell themselves to the employer. Why should they get the job?

There are a lot of people vying for a number of jobs. Because of this, it is important to be one step ahead of the pack and be ready to show them why it would be a mistake for them not to hire you. One way McGalla recommends you do that is by getting the most education possible. People look at education and they see someone that is willing to put in the time to finish something. They do not quit and they see things through all the way until the end.

There is no denying that college is expensive and it is not cheap on Bloomberg. There are loans and various other things that go into it. However, if someone wants to make more money and get a good job, that is what they have to do to get the job. As they say, anything in life worth having, you have to work for it and you have to go out there and put in the time and the schooling. It is going to pay off in ways they never thought possible, long term, so start with that education and build up the confidence.

Seattle Genetics Making a Headway in Cancer Treatment

Seattle Genetics trading in Nasdaq as SGEN is a cancer drug company based in Seattle. It is an ambitious company that is playing a great role as a cancer research station in the region.

Adcentris is the commercial drug that the company has so far produced. The drug has had over 70 trials against several categories of lymphomas.Tests are being currently undertaken are at an advanced stage. Newly identified Hodgkin lymphoma or previously untreated cases are using the drug as its primary treatment. It is hoped that the results will generate a bigger and more positive impact by the end of the year.

Seattle Genetics’ ambitious plan for 12 more drugs, 100 more employees

The drug used to fight lymphoma brought in $226 million in U.S. and Canadian countries in the past year. Sales projections in the same countries will be between $255 million to $275 million by the end of the year, 2016. This is according to the reports presented by the company. The company has partnered with Takeda Pharmaceutical which sells the drug in countries outside the U.S and Canada.

The company has 12 other drugs on trial apart from Adcetris in the development stages. They will be used to treat other diseases like myeloid leukemia. Others are targeting breast cancer and two others are specifically for bladder cancer.

To meet its demand for the workforce, Seattle Genetics is hiring professionals who will grow with the company. Plans are underway to commit 100 employees in U.S and 20 to its Switzerland office to fill the gaps. The new group will be joining 800 others who are already in the employ of the company.

Who is the man behind Seattle Genetics?

Clay Siegall Ph.D. is a Bachelor of Science degree graduate in Zoology from the University of Maryland, also an alumni of George Washington University having studied and earned a Ph.D. in Genetics.His scientific training background stressed on cancer treatments and rehabilitations

He is The Company’s President, CEO and Board Chairman He co- founded Seattle Genetics in 1988. His wide work experience gained over time having worked for the Bristol-Myers Squibb Pharmaceutical Research Institute for five years and National Institutes of Health for three years has made him an expert in his field. He also serves on other boards of Directors such as the Alder Biopharmaceuticals and Mirna Therapeutics

Seattle Genetics was built on a base of thorough investigation, Systematic invention and treatment improvement.